By Juveria Tabassum (Reuters) -Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States. Deal-making in the consumer goods industry including food, beverage, personal care, pet products and health, has been robust, with companies seeking consolidation to weather inflationary pressures, shifting consumer preferences, and intensifying competition. Here's a list of ...